Menu

Oyster Point Pharma, Inc. OYST

Full chart Compare
Set alert

Price alert · OYST

All alert types
11.17 +11.17

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $23.01MGross Profit → Expenses: $23.01MRevenue → Cost of Revenue: $1.52MExpenses → Selling, General & Admin: $95.44MExpenses → Research & Development: $24.23MExpenses → Interest Expense: $3.73MExpenses → Other Expenses: $270.00KNet Loss → Expenses: $100.66MGross Profit$23.01MNet Loss$100.66MCost of Revenue$1.52MExpenses$123.67MSelling, General & Admin$95.44MResearch & Development$24.23MInterest Expense$3.73MOther Expenses$270.00KRevenue$24.54M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

OYST annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
24.54M0000
24.54M0000
1.52M0000
23.01M0000
119.67M70.99M47.30M16.74M5.68M
24.23M39.81M33.63M13.76M3.63M
95.44M31.18M13.67M2.98M2.05M
-96.66M-70.99M-47.30M-16.74M-5.68M
3.73M000488.00K
-100.66M-70.52M-45.71M-16.50M-6.60M
-100.66M-70.52M-45.71M-16.50M-19.14M
-100.66M-70.52M-45.71M-16.50M-19.14M
-100.66M-70.52M-45.71M-16.50M-6.60M
-3.87-2.92-9.97-11.69-13.56
-3.87-2.92-9.97-11.69-13.56
-3.87-2.92-9.97-11.69-13.56
-96.92M-70.52M-45.71M-16.50M-6.11M
-96.92M-70.52M-45.71M-16.50M-6.11M
26.04M24.13M4.59M1.41M1.41M
26.04M24.13M4.59M1.41M1.41M